Knight Initiative News

Knight Initiative–supported research by Pascal Geldsetzer and colleagues adds to evidence that preventing the viral infection can help stave off cognitive decline.

New Alzheimer's biomarkers focus on whether Alzheimer's has actually begun to affect a person's thinking and memory, rather than just amyloid levels.

Psychiatrist Anna Lembke shares what scientists have discovered so far about the potential for GLP-1s in addiction treatment.

Young adults crave closeness, says Stanford psychologist Jamil Zaki, but often misjudge how much their peers want that, too. His research found strategies that can help nudge people to take a chance on one another.

Our brains and digestive tracts are in constant communication. When that communication goes off the rails, research suggests diseases and disorders can result.

This week on the podcast, Stanford psychiatry professor Erin Gibson joins us again to share the latest findings on sleep, myelin, and neurodegenerative disease.

Stanford Medicine spoke with neurologist Helen Bronte-Stewart, who conducted research that led to the development of a technology recently approved by the U.S. Food and Drug Administration.

Associate professor Jason Yeatman discusses the adoption of the Stanford-developed Rapid Online Assessment of Reading (ROAR) as a state-approved dyslexia screening tool in California.

Juliet Knowles's research has recently shown that the brain can use adaptive myelination to perfect “skills” that are actually pathological, such as having seizures.

Stanford Medicine research demonstrates a new way of detecting cells implicated in the malfunctions that cause psychiatric diseases.

Stanford University researchers have released a groundbreaking virtual reality (VR) application designed to help children prepare for MRI scans. The app, now available for free on the Oculus store, aims to reduce anxiety, improve scan quality, and educate young patients about the MRI experience.

Join us as we look back on some of the key studies we covered here at Wu Tsai Neuro in 2024 to give a (very partial) overview of the impact of our community’s research efforts this past year

We're diving back into the world of psychedelic medicine with anesthesiologists Boris Heifets and Theresa Lii, who share intriguing new data that sheds light on how ketamine and placebo effects may interact in treating depression.

With Knight Initiative support, Stanford researchers uncover a biochemical “off-ramp” in ketosis, rewriting our understanding of how ketosis influences metabolism.

Today, we are going back into the archives for a conversation with neuroscientist, entrepreneur, and best-selling author David Eagleman about the science of synesthesia. If you don't know what that is, you're about to find out.

This week, we talk with our founding director, Bill Newsome, about the 10-year legacy of the NIH BRAIN Initiative and the uncertainty for the future brought on by this year's dramatic funding cuts.

Supported by the Big Ideas in Neuroscience program, research from the Brunet lab suggests the possibility of designing pharmaceutical or genetic therapies to turn on new neuron production in old or injured brains.

Wu Tsai Neuro affiliate Carolyn Rodriguez directs the Stanford OCD Research Lab. She tells NPR there are still a lot of basics we have yet to understand about OCD.

Stanford undergraduates and local community college students showcased their summer research projects at the Wu Tsai Neurosciences Institute, highlighting efforts to introduce students to neuroscience research for the first time.

With support from a Wu Tsai Neuro seed grant, faculty affiliate Helen Bronte-Stewart and her team have developed a simple, portable device to help Parkinson's patients track their symptoms at home.